Details of the Drug

General Information of Drug (ID: DM95F8B)

Drug Name
RO-14
Synonyms Very low molecular weight heparin (venous thromboembolism), Rovi
Indication
Disease Entry ICD 11 Status REF
Phlebothrombosis GB90.3 Phase 1 [1]
Cross-matching ID
TTD ID
D08FNJ

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Antithrombin-III (ATIII) TT4QPUL ANT3_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00629733) Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of a New Ultra Low Molecular Weight Heparin (RO-14) Administered Subcutaneously Increasing Single-doses to Healthy Male Volunteers. U.S. National Institutes of Health.
2 Pharmacological effects and clinical applications of ultra low molecular weight heparins. Drug Discov Ther. 2014 Feb;8(1):1-10.